Ye Song

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.

A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.

Journal: Hepatology international
Published: April 22, 2022

Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance.

Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance.

Journal: Pathology, research and practice
Published: February 11, 2022

LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB.

LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB.

Journal: Journal of gastrointestinal oncology
Published: October 08, 2021

LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins.

LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins.

Journal: Annals of translational medicine
Published: August 26, 2021

Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.

Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.

Journal: Journal of gastrointestinal oncology
Published: May 31, 2021

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway.

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway.

Journal: Journal of hepatocellular carcinoma
Published: April 15, 2021

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression.

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression.

Journal: Cell death & disease
Published: November 11, 2020

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma.

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma.

Journal: Aging
Published: January 16, 2019

Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.

Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma.

Journal: The American journal of pathology
Published: April 13, 2017

Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.

Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.

Journal: Oncotarget
Published: July 20, 2016

MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.

MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.

Journal: Oncotarget
Published: August 11, 2014

Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.

Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.

Journal: Carcinogenesis
Published: February 11, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026